Patent details

Basic Information

Publication number:

EP3215507

PCT Application Number:

EP2015075765

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157901414

PCT Publication Number:

WO2016071426

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SYNTHESIS OF COPANLISIB AND ITS DIHYDROCHLORIDE SALT

French Title of Invention:

SYNTHÈSE DE COPANLISIB ET SON SEL DE DICHLORHYDRATE

German Title of Invention:

SYNTHESE VON COPANLISIB SOWIE DESSEN DIHYDROCHLORIDSALZ

SPC Number:

Dates

Filing date:

05/11/2015

Grant date:

26/12/2018

EP Publication Date:

13/09/2017

PCT Publication Date:

12/05/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/12/2018

EP B1 Publication Date:

26/12/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/11/2019

Expiration date:

05/11/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/12/2018

 

 

Name:

Bayer Pharma Aktiengesellschaft

Address:

Müllerstrasse 178, 13353 Berlin, Germany (DE)

Inventor

1

Name:

PETERS, Jan-Georg

Address:

Germany (DE)

2

Name:

STIEHL, Jürgen

Address:

Germany (DE)

3

Name:

LOVIS, Kai

Address:

Germany (DE)

Priority

Priority Number:

14192202

Priority Date:

07/11/2014

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07D 233/24; C07D 295/088; C07D 487/04;

Publication

European Patent Bulletin

Issue number:

201852

Publication date:

26/12/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages